article thumbnail

Governor’s 2025-26 May Revision Proposes Major Cuts to Healthcare and Undermines Medi-Cal Expansion Commitments

California Academy of Family Physicians (CAFP)

However, for individuals who do not qualify for federal Medicaid funding—such as most undocumented immigrants—the federal government does not provide matching funds, even when those individuals meet income eligibility requirements. The asset limit for a household would be $2,000 for an individual and $3,000 per couple.

article thumbnail

The Rising Tide of Medical Waste: One Model for Improvement

My Green Doctor

Single use has become the custom for most clinicians and managers, just as disposable products have become prevalent across the medical supply chain. The use of medications in U.S.

Medical 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Takes Another Small Step to Increase Naloxone Access

FDA Law Blog

Most states have some form of naloxone standing order that allows a healthcare provider to write a prescription that covers a large group of people rather than just an individual patient. syringes), to any individual without a patient-specific prescription. plies for administration (e.g.,

article thumbnail

Baby Formula Shortages

Georgetown Pediatrics & Family Medicine

Current shortages have been largely caused by supply chain issues and the recent recall of several baby formula products over concerns about contamination. Check smaller stores and drug stores, which may not be out of supply when the bigger stores are. If you can afford it, buy formula online until store shortages ease.

article thumbnail

Why, Who, When, Where and More: New Draft Guidance on Notifying FDA about Discontinuance or Interruption in Manufacturing

FDA Law Blog

blood supply; and, Manufacturers of certain finished drug products marketed without an approved NDA or ANDA. Others involved in the drug supply chain, such as third-party API manufacturers and suppliers, are not required to submit such notifications.

article thumbnail

Does the Drug Shortage White Paper Fall Short?

FDA Law Blog

Department of Health and Human Services (HHS) recently published a White Paper on Policy Considerations to Prevent Drug Shortages and Mitigate Supply Chain Vulnerabilities in the United States —with input from several HHS stakeholders, including FDA, CMS, and the Administration for Strategic Preparedness and Response. Section I.C

article thumbnail

FDA Moves Beyond COVID-19, But Impacts on COVID-19 Era Clinical Trials Remain

FDA Law Blog

For example, a disaster or public health emergency may lead to clinical trial disruptions via population quarantines, travel restrictions, various interruptions to the supply chain, and other logistical issues. In general, both of these guidances provide recommendations for sponsors to consider and analyze when a disaster (e.g.,

Clinic 64